Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

Vitamin D analogues

¹Renal Division, Washington University School of Medicine, St Louis, MO 63110, USA. abrown@imgate.wustl.edu

American Journal of Kidney Diseases : the Official Journal of the National Kidney Foundation

|November 10, 1998

Summary

This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

Redox-driven mineral and organic associations in Jezero Crater, Mars.

Nature·2025

Same author

Examining the impact of attentional focus and partner gaze on interpersonal coordination.

Psychonomic bulletin & review·2025

Same author

Partner gaze shapes the relationship between symptoms of psychopathology and interpersonal coordination.

Scientific reports·2024

Same author

Aqueously altered igneous rocks sampled on the floor of Jezero crater, Mars.

Science (New York, N.Y.)·2022

Same author

An olivine cumulate outcrop on the floor of Jezero crater, Mars.

Science (New York, N.Y.)·2022

Same author

Homogeneity assessment of the SuperCam calibration targets onboard rover perseverance.

Analytica chimica acta·2022

Same journal

Hemophagocytic Lymphohistiocytosis and Fibroblast Growth Factor 23 (FGF23)-Induced Hypophosphatemia.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same journal

Kidney Transplantation Post-Chimeric Antigen Receptor T-Cell (CAR-T) Therapy in Multiple Myeloma.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same journal

Palliative Dialysis: Putting the Person First in Dialysis Care.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same journal

Associations of Pre-Pandemic CKD With Acute and Post-Acute COVID-19: The C4R Study.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same journal

Metabolic Acidosis and Progression of CKD: Current Guidelines and Considerations.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

Same journal

Pathophysiology of Ketoacidosis: Core Curriculum 2026.

American journal of kidney diseases : the official journal of the National Kidney Foundation·2026

See all related articles

New vitamin D analogues offer therapeutic benefits for various diseases with reduced side effects. Their selectivity, achieved through interactions with specific proteins, allows for safer and more effective treatments.

Area of Science:

Endocrinology
Pharmacology
Molecular Biology

Background:

1,25(OH)2D3 (calcitriol) has broad therapeutic potential but is limited by high calcium levels.
New vitamin D analogues are being developed to retain therapeutic benefits while reducing calcemic activity.

Purpose of the Study:

To explore the therapeutic potential of novel vitamin D analogues.
To understand the molecular mechanisms underlying the selectivity of these analogues.

Main Methods:

Review of existing literature on vitamin D analogues and their interactions.
Analysis of the roles of the vitamin D receptor (VDR), serum vitamin D binding protein (DBP), and vitamin D-24-hydroxylase.
Investigation of a newly described membrane receptor's involvement.

Related Experiment Videos

Main Results:

Two analogues, calcipotriol and 19-nor-1,25(OH)2D2, are approved for psoriasis and secondary hyperparathyroidism, respectively.
Low DBP affinity contributes to reduced calcemic activity in some analogues like calcipotriol.
Mechanisms for reduced calcemic activity in other analogues, such as 19-nor-1,25(OH)2D2, are still under investigation.

Conclusions:

Vitamin D analogues demonstrate promise for treating hyperproliferative diseases, immune dysfunction, endocrine disorders, and metabolic bone disease.
Selectivity of analogues is linked to interactions with VDR, DBP, vitamin D-24-hydroxylase, and a membrane receptor.
Further understanding of molecular interactions will enable the design of improved vitamin D-based therapies.